Your Say
Health care workers administering the COVID-19 vaccine, in the presence of the Minister of State for Health and Family Welfare, Shri Ashwini Kumar Choubey, during the 1st phase of the pan India rollout of COVID-19 vaccination drive, at Dr. Ram Manohar Lohia Hospital, New Delhi on January 16, 2021.
Author: T V Padma is a science journalist based in New Delhi, with special interest in public health and research ethics
Ten days after it rolled out two vaccines in mid-January, one of which was mired in controversy, India has vaccinated more than 2.3 million people. The country, one of the world’s largest vaccine suppliers, and battling the second highest number of Covid-19 infections in the world, with more than 10 million cases[i], rolled out one the biggest immunization programs against the disease on 16 January. In doing so, it has inadvertently added to the growing number of niggling questions over blurring of lines between the urgency of a vaccine during a pandemic and
Coronavirus updates | January 24, 2021
Updated:
Updated:
January 24, 2021 23:05 IST
From next week, the Centre will expand access to Bharat Biotech’s Covaxin to seven States in addition to the existing 12, the Health Ministry said in a briefing on Saturday.
Share Article
AAA
A health worker prepares to administer a COVID-19 vaccine to a hospital staff at a government Hospital in Jammu, on January 23, 2021.
| Photo Credit: AP
From next week, the Centre will expand access to Bharat Biotech’s Covaxin to seven States in addition to the existing 12, the Health Ministry said in a briefing on Saturday.
Nearly 1.4 lakh were vaccinated until 6 p.m. with Maharashtra polling nearly 21,751 inoculations followed by Bihar at 12,165 and Andhra Pradesh at 11,562. This brings the number in the first week since the vaccination drive began to 15,37,190 healthcare workers. Across India, 27,776 sessions have been organised since last Saturday and ideally there should have been 2.7 millio
India dispatched 2 million doses of Covishield vaccines to Brazil
Ever since the coronavirus originated at Wuhan, China in December 2019, the world has come to a shocked inactivity impeding its growth. More than 96 million have been affected worldwide with 2.3 million deaths in last one year. As the world entered another year of pandemic, India, neighbour of China in Asia, has emerged as the saviour for many battered countries.
Soon after the pandemic, Indian scientists have focused on a variety of vaccines and successfully rolled out two of them – Covishield and Covaxin – manufactured by Pune-based serum Institute of India and Hyderabad-based Bharat Biotech.
Second consignment of 1,46,240 Covaxin doses arrives in Karnataka
Updated:
Updated:
January 24, 2021 08:33 IST
The fresh consignment has been stored in the walk-in coolers at the State vaccine store near Anand Rao Circle.
Share Article
File photo of vaccine being administered to beneficiaries at a Bengaluru hospital.
The fresh consignment has been stored in the walk-in coolers at the State vaccine store near Anand Rao Circle. Karnataka on Saturday received the second consignment of 1,46,240 doses of Covaxin. With this, the State has got 1,66,240 doses of Covaxin, developed by the Hyderabad-based Bharat Biotech. The fresh consignment has been stored in the walk-in coolers at the State vaccine store near Anand Rao Circle.